Logo image of WGRX

WELLGISTICS HEALTH INC (WGRX) Stock Fundamental Analysis

USA - NASDAQ:WGRX - US9495031067 - Common Stock

0.6992 USD
-0.09 (-11.09%)
Last: 10/31/2025, 8:19:35 PM
0.695 USD
0 (-0.6%)
After Hours: 10/31/2025, 8:19:35 PM
Fundamental Rating

0

WGRX gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. WGRX may be in some trouble as it scores bad on both profitability and health. WGRX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

WGRX had negative earnings in the past year.
WGRX had a negative operating cash flow in the past year.
WGRX Yearly Net Income VS EBIT VS OCF VS FCFWGRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -2M -4M -6M

1.2 Ratios

The Return On Assets of WGRX (-83.54%) is worse than 95.05% of its industry peers.
WGRX has a Return On Equity of -5004.11%. This is amonst the worse of the industry: WGRX underperforms 85.15% of its industry peers.
Industry RankSector Rank
ROA -83.54%
ROE -5004.11%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
WGRX Yearly ROA, ROE, ROICWGRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 -200 -400 -600 -800

1.3 Margins

With a Gross Margin value of 8.08%, WGRX is not doing good in the industry: 77.23% of the companies in the same industry are doing better.
WGRX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 8.08%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
WGRX Yearly Profit, Operating, Gross MarginsWGRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 -10 -20 -30

More info and screens

1

2. Health

2.1 Basic Checks

WGRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
WGRX has less shares outstanding than it did 1 year ago.
WGRX has a better debt/assets ratio than last year.
WGRX Yearly Shares OutstandingWGRX Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M 40M 50M
WGRX Yearly Total Debt VS Total AssetsWGRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

Based on the Altman-Z score of -2.99, we must say that WGRX is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -2.99, WGRX is not doing good in the industry: 87.13% of the companies in the same industry are doing better.
WGRX has a Debt/Equity ratio of 11.16. This is a high value indicating a heavy dependency on external financing.
WGRX's Debt to Equity ratio of 11.16 is on the low side compared to the rest of the industry. WGRX is outperformed by 82.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 11.16
Debt/FCF N/A
Altman-Z -2.99
ROIC/WACCN/A
WACC8.78%
WGRX Yearly LT Debt VS Equity VS FCFWGRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 5M 10M

2.3 Liquidity

A Current Ratio of 0.32 indicates that WGRX may have some problems paying its short term obligations.
The Current ratio of WGRX (0.32) is worse than 91.09% of its industry peers.
A Quick Ratio of 0.11 indicates that WGRX may have some problems paying its short term obligations.
WGRX's Quick ratio of 0.11 is on the low side compared to the rest of the industry. WGRX is outperformed by 93.07% of its industry peers.
Industry RankSector Rank
Current Ratio 0.32
Quick Ratio 0.11
WGRX Yearly Current Assets VS Current LiabilitesWGRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 10M 20M 30M

More info and screens

0

3. Growth

3.1 Past

WGRX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -160.04%.
EPS 1Y (TTM)-160.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-872.97%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%17407.64%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
WGRX Yearly Revenue VS EstimatesWGRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 5M 10M 15M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for WGRX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WGRX Price Earnings VS Forward Price EarningsWGRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WGRX Per share dataWGRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 -0.6 -0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

WGRX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WELLGISTICS HEALTH INC

NASDAQ:WGRX (10/31/2025, 8:19:35 PM)

After market: 0.695 0 (-0.6%)

0.6992

-0.09 (-11.09%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)09-08 2025-09-08
Earnings (Next)12-08 2025-12-08
Inst Owners0.76%
Inst Owner Change14.49%
Ins Owners55.29%
Ins Owner Change-1.2%
Market Cap63.91M
Revenue(TTM)36.74M
Net Income(TTM)-45302200
AnalystsN/A
Price TargetN/A
Short Float %3.08%
Short Ratio0.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.74
P/FCF N/A
P/OCF N/A
P/B 70.61
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.9
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0.4
BVpS0.01
TBVpS-0.4
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -83.54%
ROE -5004.11%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 8.08%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 11.16
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 27.13%
Cap/Sales 2%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.32
Quick Ratio 0.11
Altman-Z -2.99
F-Score4
WACC8.78%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-160.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-872.97%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%17407.64%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-113.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-358.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-250.9%
OCF growth 3YN/A
OCF growth 5YN/A

WELLGISTICS HEALTH INC / WGRX FAQ

Can you provide the ChartMill fundamental rating for WELLGISTICS HEALTH INC?

ChartMill assigns a fundamental rating of 0 / 10 to WGRX.


What is the valuation status of WELLGISTICS HEALTH INC (WGRX) stock?

ChartMill assigns a valuation rating of 0 / 10 to WELLGISTICS HEALTH INC (WGRX). This can be considered as Overvalued.


What is the profitability of WGRX stock?

WELLGISTICS HEALTH INC (WGRX) has a profitability rating of 0 / 10.